Krönke M - Search Results

1

Quantitative and Qualitative Analyses of Biodistribution and PET Image Quality of a Novel Radiohybrid PSMA, ¹⁸F-rhPSMA-7, in Patients with Prostate Cancer.

Oh SW, Wurzer A, Teoh EJ, Oh S, Langbein T, Krönke M, Herz M, Kropf S, Wester HJ, Weber WA, Eiber M. Oh SW, et al. Among authors: kronke m. J Nucl Med. 2020 May;61(5):702-709. doi: 10.2967/jnumed.119.234609. Epub 2019 Dec 13. J Nucl Med. 2020. PMID: 31836686 Free PMC article.

2

Detection Efficacy of Hybrid ⁶⁸Ga-PSMA Ligand PET/CT in Prostate Cancer Patients with Biochemical Recurrence After Primary Radiation Therapy Defined by Phoenix Criteria.

Einspieler I, Rauscher I, Düwel C, Krönke M, Rischpler C, Habl G, Dewes S, Ott A, Wester HJ, Schwaiger M, Maurer T, Eiber M. Einspieler I, et al. Among authors: kronke m. J Nucl Med. 2017 Jul;58(7):1081-1087. doi: 10.2967/jnumed.116.184457. Epub 2017 Feb 16. J Nucl Med. 2017. PMID: 28209912 Free article.

3

Exploring New Multimodal Quantitative Imaging Indices for the Assessment of Osseous Tumor Burden in Prostate Cancer Using ⁶⁸Ga-PSMA PET/CT.

Bieth M, Krönke M, Tauber R, Dahlbender M, Retz M, Nekolla SG, Menze B, Maurer T, Eiber M, Schwaiger M. Bieth M, et al. Among authors: kronke m. J Nucl Med. 2017 Oct;58(10):1632-1637. doi: 10.2967/jnumed.116.189050. Epub 2017 May 25. J Nucl Med. 2017. PMID: 28546330 Free article.

4

qPSMA: Semiautomatic Software for Whole-Body Tumor Burden Assessment in Prostate Cancer Using ⁶⁸Ga-PSMA11 PET/CT.

Gafita A, Bieth M, Krönke M, Tetteh G, Navarro F, Wang H, Günther E, Menze B, Weber WA, Eiber M. Gafita A, et al. Among authors: kronke m. J Nucl Med. 2019 Sep;60(9):1277-1283. doi: 10.2967/jnumed.118.224055. Epub 2019 Mar 8. J Nucl Med. 2019. PMID: 30850484 Free PMC article.

5

Matched-Pair Comparison of ⁶⁸Ga-PSMA-11 PET/CT and ¹⁸F-PSMA-1007 PET/CT: Frequency of Pitfalls and Detection Efficacy in Biochemical Recurrence After Radical Prostatectomy.

Rauscher I, Krönke M, König M, Gafita A, Maurer T, Horn T, Schiller K, Weber W, Eiber M. Rauscher I, et al. Among authors: kronke m. J Nucl Med. 2020 Jan;61(1):51-57. doi: 10.2967/jnumed.119.229187. Epub 2019 Jun 28. J Nucl Med. 2020. PMID: 31253741 Free PMC article.

6

First Experience Using ¹⁸F-Flubrobenguane PET Imaging in Patients with Suspected Pheochromocytoma or Paraganglioma.

Kessler L, Schlitter AM, Krönke M, von Werder A, Tauber R, Maurer T, Robinson S, Orlandi C, Herz M, Yousefi BH, Nekolla SG, Schwaiger M, Eiber M, Rischpler C. Kessler L, et al. Among authors: kronke m. J Nucl Med. 2021 Apr;62(4):479-485. doi: 10.2967/jnumed.120.248021. Epub 2020 Aug 28. J Nucl Med. 2021. PMID: 32859709 Free article.

7

Positive Predictive Value and Correct Detection Rate of ¹⁸F-rhPSMA-7 PET in Biochemically Recurrent Prostate Cancer Validated by Composite Reference Standard.

Chantadisai M, Buschner G, Krönke M, Rauscher I, Langbein T, Nekolla SG, Schiller K, Heck MM, Maurer T, Wurzer A, Wester HJ, D'Alessandria C, Weber W, Eiber M. Chantadisai M, et al. Among authors: kronke m. J Nucl Med. 2021 Jul 1;62(7):968-974. doi: 10.2967/jnumed.120.255661. Epub 2020 Nov 13. J Nucl Med. 2021. PMID: 33188151 Free article.

8

Preclinical biodistribution and dosimetry and human biodistribution comparing ¹⁸F-rhPSMA-7 and single isomer ¹⁸F-rhPSMA-7.3.

Knorr K, Oh SW, Krönke M, Wurzer A, D'Alessandria C, Herz M, Weber W, Wester HJ, Eiber M, Yusufi N, Nekolla S. Knorr K, et al. Among authors: kronke m. EJNMMI Res. 2022 Feb 4;12(1):8. doi: 10.1186/s13550-021-00872-w. EJNMMI Res. 2022. PMID: 35119557 Free PMC article.

9

Preliminary results on response assessment using ⁶⁸Ga-HBED-CC-PSMA PET/CT in patients with metastatic prostate cancer undergoing docetaxel chemotherapy.

Seitz AK, Rauscher I, Haller B, Krönke M, Luther S, Heck MM, Horn T, Gschwend JE, Schwaiger M, Eiber M, Maurer T. Seitz AK, et al. Among authors: kronke m. Eur J Nucl Med Mol Imaging. 2018 Apr;45(4):602-612. doi: 10.1007/s00259-017-3887-x. Epub 2017 Nov 28. Eur J Nucl Med Mol Imaging. 2018. PMID: 29185010

10

Single Lesion on Prostate-specific Membrane Antigen-ligand Positron Emission Tomography and Low Prostate-specific Antigen Are Prognostic Factors for a Favorable Biochemical Response to Prostate-specific Membrane Antigen-targeted Radioguided Surgery in Recurrent Prostate Cancer.

Horn T, Krönke M, Rauscher I, Haller B, Robu S, Wester HJ, Schottelius M, van Leeuwen FWB, van der Poel HG, Heck M, Gschwend JE, Weber W, Eiber M, Maurer T. Horn T, et al. Among authors: kronke m. Eur Urol. 2019 Oct;76(4):517-523. doi: 10.1016/j.eururo.2019.03.045. Epub 2019 Apr 12. Eur Urol. 2019. PMID: 30987843

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

236 results

Search Page

Filters